Aesthetics and therapeutics company scaling injectable product launches and manufacturing
Revance manufactures and distributes botulinum toxin-based aesthetics and therapeutic products across a 1,000+ person org headquartered in Nashville. The tech stack is operationally heavy — Veeva (pharma compliance), LIMS (lab data management), HPLC/UPLC (analytical chemistry instruments), GCP, Salesforce, and OneStream — reflecting a regulated biotech manufacturer's core needs. Hiring momentum is accelerating with 51 roles posted in the last 30 days, concentrated in sales (21), manufacturing (15), and finance (9), signaling aggressive commercial and operational scaling alongside product launches.
Notable leadership hires: Sales Director
Revance is a privately held biotechnology company developing and commercializing injectable products in aesthetics, skincare, and therapeutics. The organization operates as a fully integrated manufacturer, managing R&D, GMP-regulated production, regulatory compliance, and direct sales. Active projects span upstream process development, equipment qualification, method validation, and new injectable product launches. Pain points center on supplier quality, inventory accuracy, FDA compliance, and market penetration—typical friction for mid-stage biotech scaling from development into commercial distribution.
Revance develops and manufactures botulinum toxin-based products for aesthetics, skincare, and therapeutics markets. The company operates as a fully integrated biotech manufacturer with in-house production, R&D, and sales teams.
Revance's stack includes Veeva (pharma data management), LIMS (lab information systems), HPLC and UPLC (analytical chemistry), GCP (Google Cloud), and OneStream (financial planning) to manage regulated production and compliance.
Other companies in the same industry, closest in size